{"path":"Images/Pasted image 20240301132955.png","text":"- Mild Moderate Severs Anti Xa/anti lla assay Anti Xa/anti lia assay Anti Xa/antilla assay PT/INR/aPTT PT/INR/aPTT PT/INR/aPTT Fibrinogen ** Fibrinogen ** Fibrinogen** Plateletcount Platelet count Platelet count Tranexamicacid Tranexamicacid Tranexamicacid Watch and wait| Specific antidote* ** Specific antidote*** PCc/aPcc PCC/aPCC Fibrinogen concentrate Fibrinogen concentrate PRBC/FFP/Tc PRBC/FFP/Tc FVila Figure 1 Direct oral anticoa gulant (DOAC)-associsted bleedingin cardiacsurgery. The figure summarises specific (anti-Xa/ anti-lla assay) and non-specific(prothormbin time, PT; activated prothormmbin time, a PTT) laboratory diagnostics and the appropriate measures in case of mild, moderate and severe bleeding tendency in cardiac surgery. *Bleeding tendency as defined by delayed stemal dosure (DSC: nofyes); postoperative chest tube blood loss within 12 h (CTB}, transfused units of packedred blood cells (PRBO); fresh frozen plasma (FFP); the need for platelets (PLT), cryopredpitate (CRY), prothrombin complex concentrate (PCC), recombinant activated factor VIl (fFVlla)and the presence of cardiactam ponade or need for surgical re-exploration (T/R). Mild: DSC no, CTB601-800 m|, PREC 1, FFP0, PLT 0, CRY no, PCCno, rFVIla no, T/Rno. Moderate: DSC no, CTB 801-1000 mi, PREC2-4, FFP2-4, PLT yes, CRY yes, PCC yes, FMla no, T/R no. Severe: DSCyes, CTB1001- 2000 mi, PRBC 5-10, FFP 5-10, PLTN/A, CRYN/A, PCCNJ/A, iFVila no, TR yes. *Fibrinogen level (Clauss assay) or FIETEM. **Dabigatran: idanucizumab, ciraparantag or haemodialysis; Rivaroxaban/Apixaban/Edoxaban: andexanetal pha/ draparantag. ***Measures: general measures: normothermia, CaÂ®**, comection of addosis, autologous cell salvage. PCC, prothorombin complex concentrate; sPCC, adtivated prothorombin complex concentrate; PREC, packed red blood cells; FFP, fresh frazen plasme; PLT, platelet concentrate; FMlls, recombinant activated factor VIl","libVersion":"0.3.2","langs":"eng"}